Ackman Prods Allergan For Outside Review Of $46B Takeover
Activist investor Bill Ackman on Wednesday continued his assault on the governance practices at Allergan Inc., urging the drug company to hire independent counsel and advisers to evaluate a contested $46...To view the full article, register now.
Already a subscriber? Click here to view full article